Kaunia lasiophthalma
Species
KNApSAcK Entry
| Organism name | Kaunia lasiophthalma |
|---|---|
| Genus | Kaunia |
| Family | Asteraceae |
| Kingdom | Plantae |
NCBI taxonomy
Entry
| Linked NCBI taxonomy name | Asteraceae |
|---|---|
| Linked NCBI taxonomy ID | 4210 |
| Linked level | family |
Family
| Family in NCBI taxonomy | Asteraceae |
|---|---|
| ID | 4210 |
Kingdom (Superkingdom)
| Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
|---|---|
| ID | 33090 |
Plant class
| Plant class | asterids |
|---|---|
| ID | 71274 |
Metabolite list (14)
| KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
|---|---|---|---|---|---|---|---|---|
C00020626
|
[3aS-(3aalpha,7beta,7aalpha,8aalpha,8balpha,8cbeta)]-3a,4,5,7,7a,8a,8b,8c-Octahydro-7-hydroxy-6,8a-dimethyl-3-methylene-oxireno[2,3]azuleno[4,5-b]furan-2(3H)-one
|
No. 227 | No. 38 |
|
||||
|
C00020621
|
[3aS-(3aalpha,7alpha,7abeta,8abeta,8balpha,8cbeta)]-3a,4,5,7,7a,8a,8b,8c-Octahydro-7-hydroxy-6,8a-dimethyl-3-methylene-oxireno[2,3]azuleno[4,5-b]furan-2(3H)-one
|
No. 227 | No. 38 |
|
||||
|
C00020903
|
3-Hydroxydehydroleucodin
|
No. 596 | No. 38 |
|
||||
|
C00020902
|
3-Chlorodehydroleucodin
|
CHEMBL370683
|
3 / 0 / 0 | No. 596 | No. 38 |
|
||
|
C00020619
|
1beta,10beta-Epoxy-2beta-hydroxy-3-guaien-12,6alpha-olide
|
No. 671 |
|
|||||
|
C00020627
|
3beta,4beta-Epoxy-2beta-hydroxy-1(10)-guaien-12,6alpha-olide
|
No. 671 |
|
|||||
|
C00020623
|
[3aS-(3aalpha,7alpha,7abeta,8abeta,8balpha,8cbeta)]-2,3,3a,4,5,7,7a,8a,8b,8c-Decahydro-6,8a-dimethyl-3-methylene-2-oxooxireno[2,3]azuleno[4,5-b]furan-7-yl ester 2-methyl-2-propenoic acid
|
No. 843 | No. 38 |
|
||||
|
C00020622
|
[3aS-(3aalpha,7alpha,7abeta,8abeta,8balpha,8cbeta)]-7-(Acetyloxy)-3a,4,5,7,7a,8a,8b,8c-octahydro-6,8a-dimethyl-3-methylene-oxireno[2,3]azuleno[4,5-b]furan-2(3H)-one
|
No. 843 | No. 38 |
|
||||
|
C00020624
|
[3aS-[3aalpha,7alpha(E),7abeta,8abeta,8balpha,8cbeta]]-2,3,3a,4,5,7,7a,8a,8b,8c-Decahydro-6,8a-dimethyl-3-methylene-2-oxooxireno[2,3]azuleno[4,5-b]furan-7-yl ester 2-methyl-2-butenoic acid
|
No. 843 | No. 38 |
|
||||
|
C00020618
|
[3S-(3alpha,3aS*,4abeta,6aalpha,9abeta,9balpha)]-5,6,6a,7,9a,9b-Hexahydro-3-hydroxy-1,4a-dimethyl-7-methylene-3H-oxireno[8,8a]azuleno[4,5-b]furan-8(4aH)-one
|
No. 1016 |
|
|||||
|
C00020617
|
1alpha,10alpha-Epoxy-2-oxo-3,11(13)-guaiadien-12,6alpha-olide
|
No. 1016 |
|
|||||
|
C00020616
|
[3S-(3alpha,3aR*,4aalpha,6aalpha,9abeta,9balpha)]-5,6,6a,7,9a,9b-Hexahydro-3-hydroxy-1,4a-dimethyl-7-methylene-3H-oxireno[8,8a]azuleno[4,5-b]furan-8(4aH)-one
|
No. 1016 |
|
|||||
|
C00020781
|
8-Deoxyrupicolin A
|
No. 1442 | No. 38 |
|
||||
|
C00020782
|
8-Deoxyrupicolin B
/ 1alpha-Hydroxy-3,10(14),11(13)-guaiatrien-12,6alpha-olide |
No. 1442 | No. 38 |
|
Human Protein / Gene in interactions
3 ChEMBL Protein in interactions
| accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
|---|---|---|---|---|
| Q04206 | Transcription factor p65 | Transcription Factor | C00020902 | 0 / 0 |
| Q00653 | Nuclear factor NF-kappa-B p100 subunit | Transcription Factor | C00020902 | 0 / 0 |
| P19838 | Nuclear factor NF-kappa-B p105 subunit | Transcription Factor | C00020902 | 0 / 0 |